Article
Bronchial Carcinoids: From Molecular Background to Treatment Approach
20 Jan 2022
Abstract excerpt
A better understanding of the genetic and molecular background of bronchial carcinoids (BCs) would allow a better estimation of the risk of disease progression and the personalization of treatment in cases of advanced disease. Molecular studies confirmed that lungs neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs) are different entities; thus, no progression of NET to NEC is expected. In BCs, MEN1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
